Zobrazeno 1 - 10
of 13
pro vyhledávání: ''
Autor:
Valentina Poletto, Vittorio Abbonante, Alessandra Iurlo, Christian A. Di Buduo, Stefania Croce, Alessandra Balduini, Margherita Massa, Vittorio Rosti, Silvia Salmoiraghi, Paolo Bernasconi, Elisa Bonetti, Rita Zappatore, Basilio Jemos, Rita Campanelli, Irene Dambruoso, Elisa Lenta, Giovanni Barosi, Melissa Mantelli, Alessandro M. Vannucchi, Laura Villani, Paolo Catarsi, Marina Boni, Maria Antonietta Avanzini, Lorenzo Cobianchi, Paola Guglielmelli, Alessandro Rambaldi
Publikováno v:
American Journal of Hematology. 93:615-622
Splenic hematopoiesis is a major feature in the course of myelofibrosis (MF). In fact, the spleen of patients with MF contains malignant hematopoietic stem cells retaining a complete differentiation program, suggesting both a pivotal role of the sple
Autor:
Noah A. Brown, Alexandra C. Hristov, Ryan A. Wilcox, Tycel Phillips, Philip S. Boonstra, Avery Polk, Mark S. Kaminski, Nathanael G. Bailey, Tera Mayer, Sumana Devata
Publikováno v:
American Journal of Hematology. 92:1287-1294
The transcription factor GATA-3, highly expressed in many cutaneous T-cell lymphoma (CTCL) and peripheral T-cell lymphomas (PTCL), confers resistance to chemotherapy in a cell-autonomous manner. As GATA-3 is transcriptionally regulated by NF-κB, we
Autor:
Vanessa Dupoux, Lei Qian, Agata M. Bogusz, Honore T. Strauser, Richard H. G. Baxter, Sonali Majumdar, Daniel J. Landsburg, Jennifer R. Smith, April M. Schrank-Hacker, Chi Ngong Tang, Sandy Widura, Craig R. Soderquist, Stephen J. Schuster, Ang Sun, Tran Nguyen
Publikováno v:
Am J Hematol
The genetic and molecular abnormalities underlying histological transformation (HT) of nodal marginal zone lymphoma (NMZL) to diffuse large B-cell lymphoma (DLBCL) are not well known. While del(20q12) is commonly deleted in myelodysplastic syndrome i
Publikováno v:
American journal of hematology. 94(4)
Autor:
Roberto Cairoli, Alessandra Perego, Lorenza Borin, Francesco Spina, Giuseppe Rossi, Alessandra Trojani, Alessandra Iurlo, Silvia Cantoni, Michela Anghilieri, Maria Cristina Carraro, Maria Luisa Latargia, Gabriella De Canal, Ester Pungolino, Pierangelo Spedini, Mauro Turrini, Ester Orlandi, Salvatore Artale, Mariella D'Adda, Enrica Morra, Barbara Di Camillo, Milena Lodola, Francesca Lunghi
Publikováno v:
American journal of hematology. 93(7)
Publikováno v:
American journal of hematology. 93(4)
Recent work has identified distinct molecular subgroups of acute myeloid leukemia (AML) with implications for disease classification and prognosis. NPM1 is one of the most common recurrently mutated genes in AML. NPM1 mutations often co-occur with FL
Autor:
Regina Fillerova, Lenka Kruzova, Tomas Papajik, Michael Doubek, Daniel Lysák, Martina Hruba, Marek Mráz, Vít Procházka, Marie Jarošová, Eva Koritakova, Karel Indrak, Alexandra Oltová, Eva Kriegova, Karla Plevová
Publikováno v:
American Journal of Hematology. 92
Detection of genetic changes has improved the current risk stratification in chronic lymphocytic leukemia (CLL).1,2 Among the known recurrent chromosomal abnormalities,1 6q deletion is less frequent and controversy surrounding its prognostic signific
Nucleophosmin 1 ( NPM1 ) mutations in chronic myelomonocytic leukemia and their prognostic relevance
Autor:
Naseema Gangat, Katherine P. Hoversten, Terra L. Lasho, Ayalew Tefferi, Christy Finke, Mrinal M. Patnaik, Rangit Vallapureddy, Rhett P. Ketterling, Curtis A. Hanson
Publikováno v:
American Journal of Hematology. 92
Autor:
Alaa M. Ali, Jeffrey S. Miller, Kiran Vij, Daniel J. Weisdorf, Armin Rashidi, Sarah Cooley, Celalettin Ustun, Rizwan Romee, John F. DiPersio, Ryan Shanley, Peter Westervelt
Publikováno v:
American journal of hematology. 92(9)
Publikováno v:
American journal of hematology. 91(3)